SGLT2 Inhibitors and Kidney Outcomes in Patients with Chronic Kidney Disease

Globally, diabetes mellitus is a leading cause of kidney disease, with a critical percent of patients approaching end-stage kidney disease. In the current era, sodium-glucose co-transporter 2 inhibitors (SGLT2i) have emerged as phenomenal agents in halting the progression of kidney disease. Positive...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Clin Med
Main Authors: Kanduri, Swetha R., Kovvuru, Karthik, Hansrivijit, Panupong, Thongprayoon, Charat, Vallabhajosyula, Saraschandra, Pivovarova, Aleksandra I., Chewcharat, Api, Garla, Vishnu, Medaura, Juan, Cheungpasitporn, Wisit
格式: Artigo
語言:Inglês
出版: MDPI 2020
主題:
Editorial
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7564486/
https://ncbi.nlm.nih.gov/pubmed/32846935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9092723
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍